Thalidomide therapy for cicatricial pemphigoid

Daihung Jay Duong; Richard T. Moxley; Robert M. Kellman; Stephanie H. Pincus; Anthony A. Gaspari

doi:10.1067/mjd.2002.109255

Thalidomide therapy for cicatricial pemphigoid

Daihung Jay Duong
, Richard T. Moxley
, Robert M. Kellman
, Stephanie H. Pincus
, Anthony A. Gaspari

Department of Dermatology

SUNY Upstate Medical University
SUNY Buffalo
University of Rochester

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Abstract

Cicatricial pemphigoid is a chronic, presumed autoimmune, blistering disease of the mucous membranes and occasionally of the skin. The characteristic feature is scarring at the sites of healing. We report the use of thalidomide as a therapeutic agent to control previously resistant disease.

Original language	English
Pages (from-to)	S193-S195
Journal	Journal of the American Academy of Dermatology
Volume	47
Issue number	2 SUPPL.
DOIs	https://doi.org/10.1067/mjd.2002.109255
State	Published - Aug 1 2002

Access to Document

10.1067/mjd.2002.109255

Cite this

@article{ba7d93489c2a4f8db0a13d29f0ce1410,

title = "Thalidomide therapy for cicatricial pemphigoid",

abstract = "Cicatricial pemphigoid is a chronic, presumed autoimmune, blistering disease of the mucous membranes and occasionally of the skin. The characteristic feature is scarring at the sites of healing. We report the use of thalidomide as a therapeutic agent to control previously resistant disease.",

author = "Duong, \{Daihung Jay\} and Moxley, \{Richard T.\} and Kellman, \{Robert M.\} and Pincus, \{Stephanie H.\} and Gaspari, \{Anthony A.\}",

year = "2002",

month = aug,

day = "1",

doi = "10.1067/mjd.2002.109255",

language = "English",

volume = "47",

pages = "S193--S195",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Elsevier Inc.",

number = "2 SUPPL.",

}

TY - JOUR

T1 - Thalidomide therapy for cicatricial pemphigoid

AU - Duong, Daihung Jay

AU - Moxley, Richard T.

AU - Kellman, Robert M.

AU - Pincus, Stephanie H.

AU - Gaspari, Anthony A.

PY - 2002/8/1

Y1 - 2002/8/1

N2 - Cicatricial pemphigoid is a chronic, presumed autoimmune, blistering disease of the mucous membranes and occasionally of the skin. The characteristic feature is scarring at the sites of healing. We report the use of thalidomide as a therapeutic agent to control previously resistant disease.

AB - Cicatricial pemphigoid is a chronic, presumed autoimmune, blistering disease of the mucous membranes and occasionally of the skin. The characteristic feature is scarring at the sites of healing. We report the use of thalidomide as a therapeutic agent to control previously resistant disease.

UR - https://www.scopus.com/pages/publications/0036694705

U2 - 10.1067/mjd.2002.109255

DO - 10.1067/mjd.2002.109255

M3 - Article

AN - SCOPUS:0036694705

SN - 0190-9622

VL - 47

SP - S193-S195

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 2 SUPPL.

ER -

Thalidomide therapy for cicatricial pemphigoid

Abstract

Access to Document

Other files and links

Fingerprint

Cite this